뉴스벤징가
Revolution Medicines’ Pancreatic Cancer Drug Approval Validates Microcap Propanc Biopharma’s Breakthrough Survival Results
· 발표
기사 요약
Propanc Biopharma reports strong preclinical data from pancreatic cancer drug, PRP, showing over 90% tumor inhibition and extended survival.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…